| abstract |
The present application relates generally to topical formulations comprising monoterpenoid compounds which are potent inhibitors of FGF-5-dependent signalling in hair follicles or parts thereof, the manufacture of such topical formulations, and their use in reducing, delaying or preventing loss of terminal hair caused by FGF-5 signalling in hair follicles, such as in subjects suffering from or having a predisposition to developing hair loss. |